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design of gene editing in zebrafish with CRISPR/Cas9, 
and explore the potential of the combination of these two 
to support efficient functional analysis of human genetic 
variants.
Introduction
Since the publication of sequenced human genome (Inter-
national Human Genome Sequencing Consortium 2004), 
genetic variants in patients with various human genetic 
diseases can be rapidly identified by genome-wide analysis 
such as whole exome sequencing (WES), whole genome 
sequencing (WGS) and genome-wide association studies 
(GWAS), etc. (Do et al. 2012; Welter et al. 2014). Diagnos-
tic pipelines based on WES have been established and vali-
dated in certain clinical laboratories to identify sequence 
variants in patients with suspected genetic disorders, but 
only 25% of the cases have achieved the genetic diagno-
sis (Yang et al. 2013). In those undiagnosed cases, etiologic 
mutations may be located in noncoding regions that can-
not be detected by means of WES. Correspondingly, recent 
developments in WGS have also been increasingly applied 
within both the medical genetic research and the clinical 
practice (Knoppers et al. 2015). Additionally, gains in the 
diagnostic rate will be achieved through improved detec-
tion of copy-number variation which contribute substan-
tively to disease burden (Stankiewicz and Lupski 2010; Wu 
et al. 2015). Even so, analysis of NGS data alone is nor-
mally insufficient to distinguish disease-causing sequence 
variants from the many potentially functional variants, 
and false assignments of variant pathogenicity would seri-
ously impede our biological understanding of disease 
(Richards et al. 2015). Recent study has shown that even 
rare homozygous loss-of-function (rhLOF) variants could 
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be extensively revealed by NGS in healthy individuals 
and may not always be as clinically relevant as often con-
sidered (Narasimhan et al. 2016). In this case, functional 
studies showing analogous phenotypes in well-established 
cell or animal models by editing the homologous genes are 
strongly required to validate the pathogenic causality of the 
specific genes or variants (MacArthur et al. 2014).
Over the past three decades, the mouse (Mus muscu-
lus) has always been considered to be the necessary pre-
clinical model to study disease states and test new therapies 
(Dow and Lowe 2012). However, its utility in perform-
ing high-throughput analysis is challenging considering 
their small number of progeny and relatively high cost. By 
contrast, a small aquatic vertebrate, the zebrafish (Danio 
rerio), is rapidly becoming a new popular option in trans-
lational research (Gama Sosa et al. 2012). Sequencing of 
zebrafish has just been completed by the UK Sanger Insti-
tute and revealed that approximately 70% of human genes 
had functional homologs in zebrafish, suggesting most 
human pathogenesis could be modeled in zebrafish (Howe 
et al. 2013). And several logistical advantages of zebrafish 
have been gradually recognized and propelled its rise as 
an attractive model, including high fecundity, cheap hus-
bandry, external fertilization, rapid development, transpar-
ency of embryos and larvae, as well as ease of experimen-
tal manipulations. Therefore, the zebrafish may represent 
an ideal model for medium and high-throughput genetic 
research (Lieschke and Currie 2007).
Recent years have seen the continuous development of 
several types of tools for DNA manipulation, including 
zinc finger nucleases (ZFNs), transcription activator-like 
effector nucleases (TALENs), and the clustered regularly 
interspaced short palindromic repeat (CRISPR) systems 
(Gaj et al. 2013). They immensely facilitate the wide appli-
cation of genome editing in various organisms, featured by 
high site specificity, flexible design, and ease of operation. 
Particularly, CRISPR/CRISPR-associated protein 9 (Cas9) 
systems is the most rapidly developing class, which can be 
easily targeted to virtually any genomic location of interest 
by a customizable short RNA guide (Mali et al. 2013). In 
fact, the utility of CRISPR/Cas9 system extends far beyond 
functional genome editing such as knock-out and knock-
in of individual genes. Combined with specific functional 
effector domains, desired perturbations could be allowed, 
such as transcriptional control, epigenetic modulation, 
DNA labeling or inducible regulation (Hsu et al. 2014). 
And here, we mainly review the basic considerations for 
editing coding genes to uncover their function, especially 
for those revealed by NGS study of human pathogenesis. 
Recent successes and existing challenges in this field is 
summarized, and we particularly emphasize the developing 
utility of CRISPR/Cas9 system in the zebrafish platform 
for the study of human genetic diseases.
Zebrafish: a prepared model for studying human 
pathogenesis
As early as the 1930s, the zebrafish emerged as a classi-
cal developmental and embryological model in biomedi-
cal research. Since then, numerous important observations 
have been first made to answer the questions of vertebrate 
development by taking advantage of its embryological 
manipulability (Grunwald and Streisinger 1992; Amster-
dam et al. 1999). In the 1990s, thousands of fish mutants 
related to early embryonic development were identified 
through the two large-scale random mutagenesis screenings 
without sophisticated infrastructure, and utilizing these 
attributes, the zebrafish was established as a mainstream 
model in development biology (Driever et al. 1996; Haf-
fter et al. 1996). Early forward genetic screens carried out 
in zebrafish relied on the use of chemical DNA mutagens 
(ENU), followed by the isolation and characterization of 
fish individuals with the phenotypes of interest (Patton and 
Zon 2001). These experiments established the zebrafish 
as a classical model to investigate the genetics of embry-
onic patterning and development, since the phenotypes of 
these gene perturbations were easily noticeable and char-
acterized (Amsterdam and Hopkins 2006). However, three 
major disadvantages have been realized that limited the use 
of these random mutagenesis schemes: first, the positional 
cloning of the causal mutations can be costly and laborious. 
Second, random mutagenesis usually generates heterozy-
gous mutants, and recessive inherited phenotypes may fail 
to be detected in these screenings. Finally, it is impossible 
to inactivate every gene in the genome with the random 
mutagenesis, which means the depth and integrity of the 
genetic screens are inherently limited.
Soon after that, retroviral integrations were applied in 
zebrafish to facilitate insertional mutagenesis and transgen-
esis. Similar to the ENU-based random mutagenesis, large-
scale genetics screens for developmental defects were con-
ducted with retroviruses (Amsterdam et al. 2004; Varshney 
et al. 2013).And all the mutated genes are allowed to be 
identified systematically after retroviral integrations. Simi-
larly, transposons-based gene trap or enhancer trap were 
also effective in the zebrafish genome, such as Tol2, Sleep-
ing Beauty and Ac/Ds (Kawakami et al. 1998; Davidson 
et al. 2003; Choo et al. 2006). Due to their simplicity, high 
insertion efficiencies and large cargo size, they have been 
widely used in zebrafish in recent years.
To study the phenotypic consequences after perturbing 
selected genes, multiple targeted genetic approaches were 
developed. Fish geneticists injected the early embryos with 
either mRNA or antisense morpholino oligomers (MO) 
to generate a transient gene over-expression or knock-
down, and prepared zebrafish as an accessible model 
for rapid confirmation of gene functions in vertebrate 
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(Hammerschmidt et al. 1999; Nasevicius and Ekker 2000). 
Usually 25 bases in length, MOs are synthetic nucleic acid 
analogs and sterically block access of other molecules to 
complementary sequences of RNA by standard nucleic 
acid base-pairing (Summerton 1999). Injection of a MO is 
capable of preventing the translation of both zygotic and 
maternal transcripts. Importantly, recent study has shown 
that approximately 80% of morphant phenotypes in mor-
pholino treated fish were not successfully recapitulated in 
actual genetic mutants (Kok et al. 2015). The disparity was 
traditionally explained by its short acting periods (typi-
cally 2–4 days) because of degradation and dilution, and 
the uncertain off-target effect induced by increased dose of 
MO, such as non-specific p53 activation (Robu et al. 2007). 
Importantly, functional study of specific genes seems more 
complicated than expected, thus encouraging us not to rely 
completely on MO analysis.
The advantages of zebrafish, as a genetically manipu-
lable vertebrate model system, are reflected by their large 
brood size, short life cycle and easy husbandry. Hundreds 
of eggs could be fertilized externally every week, which 
are subjected to direct observations and manipulations 
under a microscope. Within the first five days, the optically 
clear fish embryos develop rapidly with no artificial feed-
ing required, and this is the most accessible time window 
to study the effects of certain genetic perturbation with-
out being confounded by environmental factors (Lieschke 
and Currie 2007). Zebrafish reach sexual maturity by three 
months of age, thus edited genes could be passed by gen-
erations from the founder lines rapidly. To examine geno-
type-phenotype correlations implicated in human diseases, 
an integrated phenotyping toolbox has been continuously 
under development, and here we only highlight the charac-
teristic benefits of fish for imaging, behavioral assays and 
gene expression profiling (Fig. 1).
These methodological advantages, offered by fish model 
as inaccessible luxuries for studies on other mammalian 
models such as mice or rats, are critical for effective func-
tional studies and drug discovery. The larval zebrafish is 
small and transparent, which allows the satisfying opti-
cal access to perform deep in vivo imaging (Fig. 1). For 
example, the unprecedented visualization of neuronal 
activity in hundreds of neurons at the same time was ena-
bled by the whole brain functional imaging techniques 
developed recently (Prevedel et al. 2014). More detailed 
structural analysis can be conducted by whole mount his-
tochemistry with a range of well-characterized histochemi-
cal markers. Moreover, optogenetic tools could reversibly 
modulate gene expressions or protein activities at the cel-
lular or circuit level with high temporal and spatial reso-
lution (Cosentino et al. 2015). Behavioral phenotypes are 
the most complex manifestations of multiple diseases, 
especially for those affecting the CNS or musculoskeletal 
systems (Stewart et al. 2014). Automated behavioral video 
tracking systems have been developed to quantify the 
fish behavior with a range of parameters on a large scale 
(Zhou et al. 2014). Corresponding functional behavioral 
tests and experimental set-ups are gradually standardized 
for both larval and adult zebrafish, proving the potential of 
zebrafish in cost-effective high-throughput screens (HTSs) 
and therapy development (Rihel et al. 2010) (Fig. 1). Apart 
from the manipulation at the genomic level, studies involv-
ing gene expression profiling are also feasible in zebrafish. 
This is particularly important to give mechanistic insights 
into the downstream events induced by the genomic pertur-
bations. In study involving early embryonic (egg to early 
gastrulation) stages, maternal transcript has been shown 
to play important roles, which can only be investigated by 
genome-wide transcriptome analysis (Aanes et al. 2011). 
Moreover, biological differences induced by gene editing 
are often more than expected. In these cases, comparing 
genomes with proteomes and transcriptomes is critical to 
understand the phenotypic change in a network-based view 
(Rossi et al. 2015) (Fig. 1).
CRISPR/Cas9: from adaptive immunity 
to genome engineering
The CRISPR system was first discovered as one of the 
many different antiviral defense mechanisms in prokaryotes 
(archaea and bacteria) against invading phages and other 
mobile genetic elements (Deveau et al. 2010; Horvath and 
Barrangou 2010; Marraffini 2015; Wright et al. 2016). The 
story started with the earliest detection of repeated copies 
downstream of the iap enzyme in E. coli, consisting of 29 
nt sequences intervened by several 32 nt spacers (Ishino 
et al. 1987). Since then, similar arrays were sequenced 
and reported in other bacteria and archaea, and these inter-
spaced sequences were named clustered regularly inter-
spaced short palindromic repeat (CRISPR) (Mojica et al. 
2000; Jansen et al. 2002). Detailed bioinformatic analysis 
of the spacers showed striking similarity to the sequences 
of certain viruses or phages that infected the particular 
prokaryotes without these spacers (Mojica et al. 2005). 
These evidences suggested that CRISPR loci might protect 
those prokaryotes against specific infections, as an adaptive 
immune system with sequence-based target specificity.
At the same time, analysis of the CRISPR loci revealed 
a conserved module adjacent to the spacers and repeats, 
named CRISPR-associated (cas) gene, based on which the 
CRISPR system was then classified into three types (I–III) 
(Jansen et al. 2002; Haft et al. 2005). As the studies of these 
three components proceeded, experimental evidences were 
collected to delineate the detailed mechanisms of CRISPR 
as sequence-based immune system (Barrangou et al. 2007). 
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For example, in the well-characterized type II CRISPR sys-
tem, spacers are derived from phage genomic sequences 
after viral challenge, and determine the target specificity of 
phage resistance by maturing into crRNA (CRISPR rela-
tive RNA), while the Cas9 nuclease provides phage resist-
ance by cleaving virus at spacer-matching regions (Brouns 
et al. 2008). Three years later, the last key component in 
CRISPR activation, a non-coding trans-activating crRNA 
(tracrRNA), was uncovered to direct crRNA maturation 
and then facilitate RNA-guided targeting of Cas9 by base-
pairing to mature crRNA (Deltcheva et al. 2011). Finally, 
as the CRISPR research was accelerated, the two-RNA 
structure formed by the hybridization of mature crRNA and 
tracrRNA was replaced by an engineered single guide RNA 
(sgRNA) to facilitate Cas9 to accomplish sequence-specific 
dsDNA cleavage (Jinek et al. 2012). With the combination 
of Cas9 and sgRNA, the integrated CRISPR system holds 
great promise to be engineered as a programmable and 
transferrable tool to accomplish genome editing (Fig. 2).
Traditional application of the CRISPR-based technol-
ogy mainly refers to functional knock-out of individual 
genes. To accomplish this, a Cas9 protein and a sgRNA 
must be introduced together into each target cell by trans-
fection or transduction. These two molecules would form 
a complex with the targeting DNA sites, a 20 nt sequence 
neighboring a protospacer adjacent motif (PAM) (Fig. 2). 
Fig. 1  The integrated phenotyping toolbox to examine genotype-
phenotype correlations in transgenic zebrafish models. The zebrafish 
develops and reaches sex maturity rapidly, thus time spent in gene 
manipulation and following phenotyping could be reduced. Once 
the transgenic fish is available, it is critical to apply the appropriate 
phenotyping tools at a right time window, which is dependent on the 
pathogenic features of the disease. And here we highlight the char-
acteristic benefits of fish for imaging, behavioral assays and gene 
expression profiling. Quantification of the phenotypes is able to gen-
erate the phenotypic barcodes, thus assisting in high-throughput anal-
ysis or chemical screening
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At this time, two endonuclease domains in the Cas9 pro-
tein produce double-stranded breaks (DSBs) in the targeted 
genomic sites, which are subsequently repaired through 
non-homologous end-joining (NHEJ). By erroneous repair 
of the DSBs, NHEJ tends to produce insertions or deletions 
(indels) mutations, therefore creating frame-shifts and loss-
of-function (LOF) mutations. On the other hand, sequence 
templates could be introduced in the process of homol-
ogy-directed repair (HDR), thus sequences of interest are 
inserted into the defined genomic sites (Fig. 2) (Auer et al. 
2014; Li et al. 2015).
Understanding of the CRISPR-Cas functionality has 
achieved tremendous progress over the past few years 
(Mohanraju et al. 2016). Correspondingly, continuous 
development of engineered CRISPR-Cas variants is pro-
viding increasing scenarios for their application in genome 
editing (Gurumurthy et al. 2016). In addition to inducing 
error-prone repair of targeted DSBs, catalytically inactive 
Cas9 (dCas9) proteins guided by sgRNAs have been used 
to repress or activate gene transcription without introducing 
irreversible mutations to the genome, which are commonly 
referred to as CRISPRi/a systems (Qi et al. 2013; Gilbert 
et al. 2013). Recently, modified Cas9 has been proved to 
be able to induce programmable editing of a target base 
in genomic DNA without double-stranded DNA cleavage 
(Komor et al. 2016). And CRISPR/Cas9 also enables pre-
cise and efficient genome editing for chromosomal struc-
tural variations (SVs) research (Park et al. 2016). This is of 
vital importance considering both SNPs and SVs contrib-
ute to serious genetic burdens (Carvalho and Lupski 2016). 
The CRISPR system has been employed in genome editing 
first in eukaryotic cells, which was then extended to mul-
tiple animal models such as zebrafish, mice, monkey, etc 
(Hwang et al. 2013; Li et al. 2013; Niu et al. 2014; Bena-
kanakere et al. 2016). Noticeably, the rapid adoption and 
extensive utility of the CRISPR/Cas9 technology were 
greatly assisted by a combination of tools and resources 
currently available (Graham and Root 2015).
CRISPR/CAS9‑edited zebrafish: a 
high‑throughput approach to translational 
research
In the recent ten years, ZFNs, TALENs and CRISPR/Cas9 
were applied in fish mutagenesis as the most successful 
demonstration of targeted gene inactivation (Doyon et al. 
2008; Huang et al. 2011; Jao et al. 2013). These nucleases-
based genome editing tools introduce gene knock-out by 
targeting the specific sites of interest with different recogni-
tion modules, induce precise DSBs at specific endogenous 
genomic loci, and finish with the error-prone DNA repair 
through NHEJ. The use of these gene-editing tools has 
proven to be revolutionary in zebrafish research, essentially 
making it an alternative model to address important ques-
tions in genetics, developmental biology, drug discovery, 
toxicology. And disease models for various genetic disor-
ders and pathological processes have been rapidly and suc-
cessfully constructed in zebrafish, including hematological 
disorders, malignancy, and neurological syndromes (Fig. 3) 
(Lieschke and Currie 2007; Ablain and Zon 2013; Kalueff 
et al. 2014).
Compared to ZFNs and TALENs, the easy programma-
bility of the DNA binding domains (sgRNAs) is the most 
advantageous feature of CRISPR/Cas system, making it the 
most amenable approach to high-throughput mutagenesis 
Fig. 2  Schematic illustration of 
the components of engineered 
CRISPR-Cas9 systems. The 
chimeric single guide RNA 
(sgRNA) interacts with the 
complementary strand of the 
DNA target site harboring an 
adjacent protospacer adjacent 
motif (PAM) sequence (blue 
and red text, respectively), 
which is recognized and cleaved 
by Cas9 nuclease (light gray 
shape). The PAM is required for 
sequence specificity of Cas9-
mediated endonuclease activity 
against genomic DNA
6 Hum Genet (2017) 136:1–12
1 3
projects (Table 1). Moreover, there are an increasing num-
ber of tools designed for CRISPR/Cas9 system in zebrafish. 
Most of them are websites or softwares designed to assem-
ble sgRNAs with minimized off-target effects based on the 
wild type genomic sequences, including CRISPR MultiTar-
geter, CRISPRdirect, CCTop, CHOPCHOP, sgRNAcas9, 
CRISPRscan and so on (Xie et al. 2014; Montague et al. 
2014; Prykhozhij et al. 2015; Stemmer et al. 2015; Naito 
et al. 2015; Moreno-Mateos et al. 2015). In addition, the 
newly developed HiTSelect is a comprehensive analysis 
pipeline for rigorously selecting screen hits and identify-
ing functionally relevant genes and pathways by address-
ing off-target effects (Diaz et al. 2015). Overall, these tools 
notably benefit the usability of CRISPR/Cas9 editing sys-
tem in zebrafish.
CRISPR/Cas9 mediated gene knock-out was first per-
formed in zebrafish by Hwang et al. with somatic mutagen-
esis rates ranging from 24 to 59% in 10 loci (Hwang et al. 
2013). Like other reagents, characterization of its off-
target effects is challenging. Previous work indicated that 
DSB could be induced by Cas9 even when small inser-
tions (DNA bulge) or deletions (RNA bulge) existed in the 
DNA sequence compared to the RNA guide strand (Lin 
et al. 2014). However, whole genome sequencing to iden-
tify the off-target events of CRISPR/Cas9 in cells revealed 
low incidence of off-target mutations (Veres et al. 2014). 
Meanwhile, collective evidence showed that the off-target 
effect was related to the characteristics of the mismatch 
nucleotides, such as its number and identity (Fu et al. 2013; 
Hsu et al. 2013; Pattanayak et al. 2013). And 3′ end of the 
sgRNA sequence may be of particular importance with 
regard to its specificity (Cong et al. 2013). Computational 
tools are also developed to predict the off-target and on-
target scores (Haeussler et al. 2016). However, the unbiased 
measurement of the off-target effects has not been per-
formed in zebrafish. Limited insights can be gained from 
the recently conducted high-throughput gene targeting 
study using CRISPR/Cas9, in which mutations was gen-
erated in 99% of the genes tested and germline transmis-
sion was achieved in 28% of them (Varshney et al. 2015). 
Fig. 3  The developing utility of zebrafish in research of disease mod-
eling. It shows above the timeline of important disease model stud-
ies and technological developments in zebrafish research. The line 
represents the evolution of the number of PubMed publications on 
zebrafish per year between 1983 and 2013. Earliest models of por-
phyria and other hematologic disorders could date back to 1983. As 
shown in the figure, the use of zebrafish in modeling human diseases 
has increased dramatically over the past years, benefiting from the 
development of several tools including morpholino, ZFNs, TALENs 
and CRISPR/Cas9
Table 1  Comparison of ZFN, TALEN and CRISPR/Cas9 techniques
ZFN zinc finger nuclease, TALEN transcription activator-like effector nuclease, sgRNA single guide RNA
Tool name Target sequence Recognition module Transmission efficiency Throughput
ZFN Every 140–400 bp Zinc finger domain Low Low
TALEN Every 1–3 bp TALE Variable Moderate
CRISPR/Cas9 N20-PAM sequence sgRNA High High, proper for reverse genetic screening
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At certain sites, the efficiency of the CRISPR/Cas9 system 
can reach up to 98%, and the rates of mutagenesis at poten-
tial off-target sites are low (1–3%) (Hruscha et al. 2013). 
However, it is still highly recommended to observe the phe-
notypes of the mutant fish across generations to dilute irrel-
evant alleles with off-target events.
However, a broader range of DNA sequence modi-
fications is highly desirable such as locus-specific SNP 
introduction or gene insertion, considering that proposed 
pathogenesis models of the associated genes revealed by 
NGS technology can be highly diversified (Stankiewicz 
and Lupski 2010; Do et al. 2012; Varshney and Burgess 
2014). HDR-mediated genome editing has been success-
fully employed in zebrafish after co-injection of a donor 
plasmid. However, this remains a low-efficiency process 
especially when integrating a relatively long DNA frag-
ment in targeted sites (Auer et al. 2014). In this context, 
genome-specific knock-in techniques in zebrafish are still 
under improvement and intron-based knock-in approaches 
in zebrafish was newly developed using the CRISPR/
Cas9 system (Li et al. 2015). Inspiringly, if the efficacy of 
CRISPR/Cas9 system is constantly improved to a reliable 
level, phenotypes can directly be assayed in the injected 
embryos. And this seems more practical since Varshney 
et al. designed a high-throughput targeted mutagenesis 
pipeline in zebrafish with the CRISPR/Cas9 system (Var-
shney et al. 2015). They targeted two different loci for each 
gene and had a 99% success rate for generating mutations 
across 83 genes, with half of their injected embryos trans-
mitting mutations through the germline to the next genera-
tion. Moreover, organ-specific phenotypic screenings or 
functional observations could routinely be conducted in the 
transgenic fish with fluorescent organs, thus dramatically 
reducing the evidence collection time for the perturbed 
genes (Fig. 4) (Shah et al. 2015; Varshney et al. 2015).
In modeling diseases with zebrafish, choice between 
MO and CRISPR/Cas9 system is highly dependent on the 
specific situation. Detailed comparison of these two tools 
is listed in Table 2. While MO is a traditional tool that has 
been used in functional knock-down of numerous genes, 
CRIPSR/zCas9 system is an integrated toolbox to accom-
plish functional gene perturbations including both loss 
of function and gain of function experiments, with rapid 
development expected in the near future (Auer et al. 2014; 
Varshney et al. 2015). MO is designed for the exploration 
of phenotypes in early developmental stage of the fish. The 
typical time point to observe phenotypes in a CRISPR-
Cas9 mediated transgenic fish is after the generation of 
F2, which generally takes more than six months. Recent 
study has showed optimal results proving the possibili-
ties to examine phenotypes in a high-throughput manner 
in F1, which can be available within three months (Varsh-
ney et al. 2015). Interestingly, enormous disparity in the 
phenotypes between the previously reported MO treated 
fish and recently generated transgenic fish was reported 
(Kok et al. 2015). The use of MO is seemingly discour-
aged considering both the unrepeatable phenotypes and 
the easy access to the CRISPR-Cas9 systems. However, 
another study showed that complete gene knock-out could 
induce genetic compensation by other related genes, which 
ablated the phenotypes seen with MO (Rossi et al. 2015). 
And more complete gene knock-out is accomplished in 
MO experiments since the compensation does not happen 
with MO. Meanwhile, several other potential issues can-
not be ignored in generating fish mutant. First, successful 
functional knock-out has to be validated, since alternative 
starting sites of transcription or splicing sites may exist in 
certain genes. Hypomorphic alleles may also be generated 
with minimal functions reserved. To be concluding, the 
choice between MO and CRISPR/Cas9 system is not mutu-
ally exclusive, but complementary to each other.
A number of successful studies have exploited the 
CRISPR/Cas9-mediated zebrafish to test the causal role 
of specific genetic perturbations in a ‘genotype-to-pheno-
type’ approach (Hwang et al. 2013; Jao et al. 2013; Shah 
et al. 2015; Varshney et al. 2015). For example, Perles et al. 
employed the CRISPR/Cas9-mediated zebrafish to investi-
gate the effect of MMP21 knock-out (Perles et al. 2015). 
MMP21 gene was suggested to be associated with human 
heterotaxy. However, few studies had verified the under-
lying mechanism and its role in pathogenic pathway. Car-
diac looping defects were observed in zebrafish embryos 
with MMP21 deleted, together with concomitant defects in 
Notch signaling. Moreover, the precision of CRISPR/Cas9 
editing is utilized to isolate phenotype-causing genes in dif-
ficult genomic regions. Cloche is a gene that plays critical 
roles in haemato-vascular development, and the isolation of 
cloche is particularly difficult due to its telomeric location. 
Reischauer et al. systematically genome-edited each can-
didate genes in the cloche-containing region and success-
fully isolated the cloche gene, which greatly facilitated the 
following functional investigation of the gene in haemato-
vascular specification pathways (Reischauer et al. 2016). 
These are typical case showing that genomic functional 
studies could be easily conducted with the combination of 
the CRISPR/Cas9 system and zebrafish.
In addition, multiplex biallelic genome editing can also 
be achieved simultaneously in CRISPR-edited zebrafish 
model (Jao et al. 2013). This can facilitate the recapitula-
tion and observation of multiple phenotypes caused by 
multiple genes in the same clutch of fish, which is particu-
larly important when a set of disease-associated genes are 
concurrently revealed by NGS studies or gene–gene inter-
actions are under investigation. Moreover, multiplex condi-
tional mutagenesis is particularly important to investigate 
the function of genes in a tissue-specific manner. Instead 
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of injecting synthesized Cas9 and sgRNAs, these two ele-
ments are incorporated into the fish genome downstream 
of tissue-specific promoters. Similarly, with the Cas9 and 
sgRNA generated in the same cells, DSBs are induced and 
genome editing can be accomplished (Yin et al. 2015). Due 
to the ease of large-scale screening in zebrafish, CRISPR/
Cas9-edited zebrafish model can expand the capacity of 
genome editing to study human genetic disease in a net-
work-based approach (Barabasi et al. 2011; Jao et al. 2013; 
Shah et al. 2015; Varshney et al. 2015).
Future development and promises
The combination of CRISPR-Cas9 system and zebrafish 
holds great promise for studying human genetic diseases. 
By various GWAS and exome sequencing studies, candi-
date disease genes are being identified continuously, of 
which the function needs to be validated in an easy and 
fast approach. Zebrafish is an ideal biological system in 
this case particularly considering its similarity to human 
biology and unusual speed to perform effective functional 
Fig. 4  A high-throughput targeted mutagenesis pipeline to study 
human genetic disease with the combination of CRISPR-Cas9 sys-
tem and zebrafish. Phenotypes of a certain disease or syndrome are 
characterized and categorized in details, as a clinical reference for 
animal model characterizations. Depending on the genetic research 
background of the disease, individual sgRNA could be constructed 
and injected into either the yolk or the cell of one-cell stage embryos. 
When information of candidate genes or mutations is limited, sgRNA 
library is also easily constructed in the 96-well format with one tar-
get-specific sequence and the other a generic oligonucleotide that 
contains the remaining nucleotides required in a sgRNA. Similarly, 
individual sgRNA is injected into the fish embryos. The founder 
fish are often outcrossed to wild type to generate heterozygous F1 
(3 months) and F2 fish (6 months), and phenotype-genotype analy-
sis is carried out in the F2 fish as shown in Fig. 1. In certain screen-
ing design, phenotyping can be performed in F0 or F1 fish to reduce 
the timeline, although off-target effects are more concerned in this 
approach. With the proper phenotypes characterized, the potential 
causal link between genotypes and phenotypes can be drawn. Further 
design of studies may include chemical screenings based on the par-
ticular phenotype in fish, thus improving our understandings of the 
pathogenesis and accelerating therapy development
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studies and drug discovery (Fig. 4). Based on the gene-
related hypothesis of the disease, sgRNAs could be con-
structed and injected into fish stage embryos. In contrast, 
with limited information of candidate genes or mutations, 
sgRNA library is also easily constructed in the 96-well 
format with one target-specific sequence and the other a 
generic oligonucleotide that contains the remaining nucleo-
tides required in a sgRNA (Varshney et al. 2015). Various 
mutant fish are conveniently identified and phenotypes of 
a certain disease model are characterized and categorized 
in details, referring to the clinical symptoms and signs 
observed in patients (Fig. 3). Finally, chemical screening is 
ready to be performed in a phenotype-based approach, as 
described in previous studies (Kokel et al. 2010; Kawahara 
et al. 2011; Baraban et al. 2013).
Better mutagenesis is expected with the optimization 
of the zebrafish CRISPR technology. Engineered Cas9 
slightly different from that used in other systems has shown 
better expression and nuclear localization, thus contribut-
ing to higher efficiency (Jao et al. 2013). Similarly, modifi-
cations in the sgRNA sequence are also shown to improve 
mutagenesis rates (Hwang et al. 2013; Jao et al. 2013). 
However, genome-wide unbiased evaluation of the off-
target has not been performed for CRISPR/Cas9 in the 
zebrafish, and unidentified off-target modifications in the 
fish genome may cause false-positive annotation of the 
gene functions. Despite the promising results, demonstra-
tion of the same high levels of mutagenesis accuracy and 
efficiency across a wider range of genes and phenotypes is 
needed. Moreover, various genetic perturbations, including 
knock-out, knock-down and over-expression, are comple-
mentary methods to obtain a comprehensive understanding 
of the causal links between genes and phenotypes. Com-
bined with other traditional tools in zebrafish such as MO, 
possibilities of using CRIPSR/Cas9 systems still need to 
be extended with improvement in the technology and study 
designs.
Conclusion
The wide use of next-generation sequencing has caused 
explosive identification of potential disease-causing 
variants. The proper design to understand the func-
tion of genetic elements in biological systems is neces-
sary. Recently, zebrafish has become the trending animal 
model for investigating human genetic variants and dis-
eases, supported by its genetic similarity to human and 
outstanding manipulability. Traditionally, zebrafish is the 
preferred model for studying vertebrate development, and 
its abundant research background comes with a number 
of technologies including gene-editing tools and inte-
grated phenotyping methods. The recent three years has 
witnessed the sea change CRISPR/Cas9 has created in our 
ability to perform targeted gene perturbations in zebrafish, 
with high levels of on-target efficiency and relatively 
low off-target modifications. In addition, the CRIPSR/
Cas9 derived toolbox is still under active develop-
ment, and more comprehensive designs can be available 
with the introduction of conditional gene modification, 
Table 2  Comparison of CRISPR/Cas9 system and MO in disease modeling with zebrafish
KO knock-out, KD knock-down, KI knock-in, MO morpholino oligomers
CRISPR/Cas9 system MO
Targeted loss of function Cas9 induces indels and frame-shifts (KO); CRISPRi represses gene 
transcription
Translation of target genes are blocked (KD)
Targeted gain of function Sequences are inserted with templates co-injected with Cas9 (KI); 
CRISPRa activates gene transcription
Unavailable
Timeframe In KO and KI studies, phenotypes can be observed in F0 (0–5d), F1 
(3 m) or F2 (>6 m), off-target effects need to be considered in early 
generations
Phenotypes can be observed in F0 (0–5d)
Cost and throughput Relatively cheap and high-throughput, depending on the study design 
and individual institutes
Cheap and high-throughput
On-target efficacy Highly variable depending on the design and target sequence
Gene dosage modulation Complete KO is accomplished with a coding frameshift. Gene dosage 
modulation can be done with CRISPRi/a
Complete KO is generally not available
Conditional function Conditional gene editing is accomplished with conditional Cas9 
expression
Generally not available
Duration of the effect KO or KI is permanent and can be transmitted through generations Transient KD
Reversibility Cas9 KO is irreversible, CRISPRi/a is reversible Reversible
Toxicity Highly variable among the different sgRNAs, not correlate with the 
on-target efficacy
Increase with the MO dose injected
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multiplex biallelic genome editing and dCas9-medicated 
transcriptional regulations. High-throughput screens for 
phenotypic effects are facilitated by the combination of 
CRISPR/Cas9 systems and zebrafish, thus benefiting ther-
apy development.
In conclusion, CRISPR/Cas9-editing in zebrafish is a 
reliable and promising method for genetic diseases mod-
eling and medical genetic research.
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